Connection
Elizabeth Kessler to Drugs, Investigational
This is a "connection" page, showing publications Elizabeth Kessler has written about Drugs, Investigational.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.086 |
|
|
|
-
Bowles DW, Kessler ER, Jimeno A. Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib). Drugs Today (Barc). 2011 Nov; 47(11):857-68.
Score: 0.086